Clinical Trials (PDQ®) - National Cancer Institute

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights

	Related Links


	Educational Materials About Clinical Trials Clinical Trials: Questions and Answers Questions to Ask Your Doctor Drug Information from MedlinePlus

Preoperative Assessment of Colon Tumor

Basic Trial Information
Trial Description
Summary
Eligibility Criteria
Trial Contact Information

Basic Trial Information

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV

Diagnostic

Active

18 and over

Other

KA05028-MA
KA05028, NCT00114829

Trial Description

Summary

The purpose of this study is to determine whether a colonic tumor can be classified as malignant or benign with magnetic resonance (MR) colonography. Patients with a verified colon carcinoma or benign tumor based on diverticulitis are offered a MR colonography with intravenous (I.V.) contrast. The tumor is classified as malignant or benign by assessing the dynamic contrast uptake and morphology. The Investigator is blinded from the verified diagnosis and the MR classification is compared to the histological diagnosis.

Eligibility Criteria

Inclusion Criteria:

Colorectal cancer

Colorectal tumor

Exclusion Criteria:

Active diverticulitis

Pacemaker

Metal in the body

Claustrophobia

Trial Contact Information

Trial Lead Organizations/Sponsors

Copenhagen County Herlev University Hospital

Gentofte Hospital

Michael P Achiam, M.D.

Principal Investigator

Michael P Achiam, M.D		Ph: +45 44884391
		Email: achiam1@dadlnet.dk

Trial Sites

Denmark

Herlev

Copenhagen County Herlev University Hospital

Michael P Achiam, M.D Ph: +45 44884391

Email: achiam1@dadlnet.dk

Michael P Achiam, M.D. Principal Investigator

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00114829
Information obtained from ClinicalTrials.gov on May 27, 2008

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.